Outcome of a public consultation on the Draft Scientific Opinion of the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) on the update of the tolerable upper intake level for vitamin D for infants

Abstract

The European Food Safety Authority (EFSA) carried out a public consultation to receive input from the scientific community and all interested parties on the draft Scientific Opinion on the update of the tolerable upper intake level for vitamin D for infants. This draft Scientific Opinion was prepared by the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA Panel) and endorsed by the Panel for public consultation by written procedure on 9 April 2018. The written public consultation for this document was open from 18 April 2018 to 23 May 2018. EFSA received comments from 4 interested parties. EFSA and its NDA Panel wish to thank all stakeholders for their contributions. The current report summarises the outcome of the public consultation, and includes a brief summary of the comments received and how the comments were addressed. The NDA Panel prepared an updated version of the Scientific Opinion on the update of the tolerable upper intake level for vitamin D for infants taking into account the comments received. The Scientific Opinion was discussed and adopted at the NDA Plenary meeting on 28 June 2018, and is published in the EFSA Journal.Comments received 4. Comment was made that the risk assessment modelling should have included supplementation, and that omission of any allowance for supplementation in the intake assessment undertaken by the Panel leads to an underestimation of the risk of exceeding the UL. Reference was also made to the margins, considered as low by the commenter, between the estimated P95 of vitamin D intake in formula consumers and the ULs, in the different intake scenarios considered.